Press release
Nonerosive Reflux Disease Treatment Market Segments, Dynamics, Treatment Agents Current Trends and Challenges Forecast - Global Review 2018 to 2026
Fact.MR
Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=1098
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease. Proton pump inhibitors (PPI) are therapeutically most efficient drugs in nonerosive reflux disease treatment though complete symptom control is low. H2 – blockers have low success rate in nonerosive reflux treatment but are having high usage. Reduced success rate of proton pump inhibitors in patients with GERD and heartburn is attributed to co-existing nonerosive reflux disease. Success of antireflux surgery in nonerosive reflux disease treatment is low when compared to erosive reflux disease. Antacids, Proton pump inhibitors and H2 – blockers are used in nonerosive reflux disease treatment and in case of chronic cases antireflux surgery is done.
The global nonerosive reflux disease treatment market is classified on the basis of product type, distribution channel and region
Based on the drug type nonerosive reflux disease treatment market is segmented into following:
• Proton pump inhibitors
• H2 – blockers
• Antacids
• Prokinetics
Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1098
Based on the distribution channel nonerosive reflux disease treatment market is segmented into following:
• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
On the basis of geography, global nonerosive reflux disease treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Region wise North America is most lucrative market due increased prevalence of gastroesophageal reflux disease (GERD) and heartburn. Health related lifestyle correlating to obesity in North America is responsible for increasing nonerosive reflux disease treatment market and is only expected to grow. Nonerosive reflux disease is most common in patients with GERD and prevalence of gastroesophageal reflux disease (GERD) in North America (20%), Europe (9-17%) Asia Pacific (2-5%) once a week which is further responsible for nonerosive reflux disease treatment.
Key major players in the nonerosive reflux disease treatment market are: AstraZeneca plc, Eisai Co, GlaxoSmithKline PLC; Takeda Pharmaceutical Co., Ltd, Johnson & Johnson, Daewoong Pharmaceutical Co., Ltd.; Ironwood Pharmaceuticals, Inc.; SRS Pharmaceuticals Pvt. Ltd.; and SFJ Pharmaceuticals Group
The report covers exhaustive analysis on:
• Nonerosive reflux disease treatment Market Segments
• Nonerosive reflux disease treatment Market Dynamics
• Historical Actual Market Size, 2013 - 2017
• Nonerosive reflux disease treatment Market Size & Forecast 2018 to 2024
• Nonerosive reflux disease treatment Agents Current Trends/Issues/Challenges
• Competition & Companies involved
• Nonerosive reflux disease treatment Market Drivers and Restraints
Ask From the Experts@ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1098
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market Research Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonerosive Reflux Disease Treatment Market Segments, Dynamics, Treatment Agents Current Trends and Challenges Forecast - Global Review 2018 to 2026 here
News-ID: 1143964 • Views: …
More Releases from Fact.MR
Intracranial Aneurysm Market is Expamding at a CAGR of 10.5% by 2035 |
The global intracranial aneurysm market is poised for robust growth over the next decade, as innovations in treatment techniques and a growing focus on early detection fuel demand. According to the latest market research, the industry is projected to expand at a strong CAGR of 10.5% during the forecast period from 2025 to 2035. This growth trajectory is expected to elevate the market value from USD 1,626 million in 2024…
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 | Avantor, Charter Medica …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate…
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 Driven by Automation in A …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate…
Remote Control Market is Expanding at a CAGR of 4.8% by 2034 | Omni Remote; Zeni …
The global remote control market is on a steady growth trajectory, underpinned by rapid technological advancements and the growing penetration of smart consumer electronics. According to the latest projections by Fact.MR, the market, valued at USD 26.4 billion in 2024, is expected to expand at a CAGR of 4.8% during the forecast period from 2024 to 2034, reaching USD 42.1 billion by the end of 2034. As households and industries…
More Releases for Nonerosive
Medical Waste Containers Market Outlook 2021 to 2031: Growth Insights with Steri …
The global medical waste containers market is experiencing significant growth momentum, projected to reach US$ 36 billion by 2031, expanding 1.8x from its 2021 valuation of US$ 20 billion. This steady rise is underpinned by increasing volumes of healthcare waste-especially non-infectious waste, which is expected to account for around 40% of total demand for medical waste containers.
The COVID-19 pandemic amplified the urgency of safe medical waste handling. From disposable PPE…
Nonerosive Reflux Disease Treatment Market 2031 Report Enlightening Development …
The research report presents a market assessment of the Nonerosive Reflux Disease Treatment market and contains thoughtful insights, facts, and historical data and statistically supported and industry-validated market data
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry
250 page market research report by Fact.MR, ( leading business and competitive intelligence provider),…
Proton Pump Inhibitors Reflux Disease Treatment Size & Share Expanding Across Th …
The latest market research report titled “Proton pump inhibitors reflux disease treatment Market” methodically summarizes key elements of Proton pump inhibitors reflux disease treatment Market research. The report provides an in-depth study of the Proton pump inhibitors reflux disease treatment Market, highlighting the latest growth trends and dynamics in the Proton pump inhibitors reflux disease treatment Market. The report is intended to assist readers in accurately assessing current and future…
Nonerosive Reflux Disease Treatment Market Scenario Highlighting Major Drivers & …
Various studies have concluded that patients with nonerosive reflux disease have 20 to 30% less chances of getting relief from acid-blocking drugs hence making it difficult to treat nonerosive reflux disease with PPI. Non-availability of efficient treatment acting as a restraint in Nonerosive Reflux Disease Treatment Market growth. Difficulty in diagnosis of nonerosive reflux disease further makes treatment difficult attributing to low nonerosive reflux disease market growth. Higher doses of…
Nonerosive Reflux Disease Treatment Market to Reap Excessive Revenues by 2018 to …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
Nonerosive Reflux Disease Treatment Market: Outlook, Opportunity and Demand Anal …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.…
